Skip to content
Screener

Evolent Health, Inc. EVH Reportable segment — Revenue

Similar metrics at other companies

Analog Devices logo
ADIReportable Segment — Revenue
$3.62B+37.2%
Credo Technology Group Holding Ltd logo
CRDOReportable Segment — Revenue
$437M+157%
Zscaler logo
ZSReportable Segment — Revenue
$850.48M+25.4%
Zoom Video Communications, Inc. logo
ZMReportable Segment — Revenue
$1.24B+5.5%
Snowflake logo
SNOWReportable Segment — Revenue
$1.39B+33.5%
CWA
CWANReportable Segment — Revenue
$221.23M+74.4%

Other financials

Income statement

See full
Revenue$652.5M+46.9%
Gross profit$80.8M-19.5%
Operating income-$9.6M-716%
Net income-$28.4M-42.6%
EPS (diluted)-$0.25+43.2%

Balance sheet

See full
Cash & equivalents$115.7M-23.4%
Total debt$970.4M+13.7%
Total equity$383.2M-57.2%
Total assets$2.0B-19.9%

Cash flow

See full
Operating cash flow-$9.3M+69.3%

Valuation

See full
Market cap$446.58M-58.2%
Enterprise value$1.3B-26.5%
P/S0.2×-0.3×

Profitability

See full
Gross margin17.2%+0.9pp
Operating margin-20.4%-22.4pp
Net margin-24.1%-35.8pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-79%-99.2pp
Debt / equity2.5×+1.6×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:53 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628908-26-000086
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Revenue$652,520$444,328$1,148,766$927,977
Less:
Medical expense and device costs (1)493,023249,161828,385541,838
Cost of revenue excluding medical expense and device costs and other segment items (2)77,96693,732154,557181,576
Selling, general and administrative expenses excluding other segment items (3)53,48163,888115,707130,156
Depreciation and amortization expenses21,56623,14143,12147,199
Interest income(703)(1,084)(1,717)(2,358)
Interest expense16,85911,60133,72721,986

Item 1. Financial Statements

FAQ

What is Evolent Health, Inc.'s reportable segment — revenue?
Evolent Health, Inc. (EVH) reported reportable segment — revenue of $652.52M in Q2 2026.
How has Evolent Health, Inc.'s reportable segment — revenue changed year-over-year?
Evolent Health, Inc.'s reportable segment — revenue increased by 46.9% year-over-year, from $444.33M to $652.52M.
What is the long-term trend for Evolent Health, Inc.'s reportable segment — revenue?
Over 3 years (2022 to 2025), Evolent Health, Inc.'s reportable segment — revenue has grown at a 11.5% compound annual growth rate (CAGR), from $1.35B to $1.88B.
What does reportable segment — revenue mean?
This represents the total gross income generated by the primary business segment through its healthcare delivery and payment services. It serves as a key indicator of the segment's market reach and the scale of its value-based care operations.

Ask your AI about Evolent Health, Inc.'s reportable segment — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude